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Abstract 
P2X2 receptors, with other P2X receptor subtypes, have an important role mediating 
synaptic transmission in regulating the functions of the gastrointestinal tract. Our 
recent work has found a new regulator of P2X receptor function, called Pirt 
(phosphoinositide interacting regulator of transient receptor potential channels). In 
the present work, we have shown that Pirt immunoreactivity was localized in nerve 
cell bodies and nerve fibres in the myenteric plexus of the stomach, ileum, proximal 
and distal colon, and in the submucosal plexus of the jejunum, ileum, proximal and 
distal colon. Almost all the Pirt-immunoreactive (ir) neurons were also P2X2-ir, and 
co-immunoprecipitation experiments have shown that Pirt co-precipitated with the 
anti-P2X2 antibody. This work provides detailed information about the expression of 
Pirt in the gut and its colocalisation with P2X2, indicating its potential role in 
influencing P2X2 receptor function. 
 
 
Introduction 
 
Morphological and functional data have shown that P2X receptors regulate the 
functions of the gastrointestinal tract [1, 2] and are potential targets for drug 
treatment for gastrointestinal diseases, including irritable bowel syndrome [2-4]. The 
P2X receptor is composed of seven subunits, denoted P2X1 to P2X7, which can 
assemble to form either homo- or heterotrimeric channels, giving rise to a wide 
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range of phenotypes [5]. 
 
The distribution of P2X receptors in the enteric nervous system of the gut has been 
described in various species. In guinea pig, by using immunohistochemical methods, 
P2X2 [6] and P2X3 [7, 8] receptors have been found in the enteric nervous system 
where they are expressed on inhibitory motor neurons and non-cholinergic 
secretomotor neurons mediating fast synaptic transmission [9], while only the P2X2 
subunit is expressed on intrinsic primary afferent neurons in the ileum. 
Immunoreactivity for the P2X7 receptor was widely distributed surrounding ganglion 
cell bodies and associated with nerve fibers in both myenteric and submucous 
plexuses [10]. In the myenteric plexus of the human colon, P2X3 subunits were found 
to coexist with Calbindin D28K, a marker for intrinsic sensory neurons. In rats, P2X2- 
and P2X3-immunoreactive (ir) neurons were found in the myenteric and submucosal 
plexuses throughout the entire length of the digestive tract from the stomach to the 
colon [11]. P2X6 receptors were expressed widely in the submucosal and myenteric 
plexuses and P2X4 receptors were not expressed in neurons, but were expressed in 
macrophages of the gastrointestinal tract [12]. In mouse, P2X5 receptor 
immunoreactivity was widely distributed in myenteric and submucosal plexuses 
throughout the gastrointestinal tract [13].  
 
In our previous studies [11], we have shown that the P2X2 receptor is the dominant 
subunit in the rat gut. It is co-expressed with Calbindin and Calretinin in both 
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submucosal and myenteric plexuses, which implies a role in gut pain. However, little 
is known about how its functions are regulated. Extensive evidence has revealed that 
the interactions of P2X2 receptors with cellular macromolecules influence its 
localization, surface expression and trafficking, channel activation, desensitisation 
and ion selectivity [14]. Pirt (phosphoinositide interacting regulator of transient 
receptor potential (TRP)), a phosphoinositide-binding protein [15], may be a new 
macromolecule involved in regulating P2X2 receptor activities. 
 
Pirt is a 135 amino acid membrane protein with both N and C termini in the 
cytoplasm. In situ hybridization studies have revealed that it is expressed specifically 
in the peripheral nervous system (PNS), predominantly on nociceptive neurons in the 
dorsal root ganglia (DRG) and trigeminal neurons. Weaker staining was also noted in 
other parts of the PNS, including sympathetic and enteric neurons. Pirt has been 
identified as a regulatory subunit of TRP vanilloid 1 (TRPV1), playing an important 
role in noxious heat, capsaicin [15] and uterine contraction-induced pain [16]. It also 
has a role in histamine-dependent and -independent itch [17]. Pirt has a role in 
detecting cold via regulating the function of TRPM8 [18]. In our recent work, Pirt was 
found to reduce bladder overactivity by inhibiting P2X3 receptors in bladder nerve 
fibres [19], which led to the current study of the potential relationship between Pirt 
and the P2X2 receptor subtype. 
 
In this study, we have found a wide expression pattern of Pirt protein in the gut and 
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their co-localization with P2X2 receptors by immunohistochemical methods. In 
co-immunoprecipitation experiments, we found evidence that Pirt protein and P2X2 
receptors functionally interact in the gut. 
 
Materials and methods 
Animals 
 
All animal procedures followed the principles of good laboratory animal care and 
experimentation in compliance with the National Institutes of Health Guidelines on 
the Use of Laboratory Animals and approved by the Second Military Medical 
University Committee on Animal Care. Male Pirt knockout (-/-) mice and wildtype 
(WT) littermates with the C57BL/6 background were provided by Dr. Zong-Xiang Tang  
at the Nanjing University of Traditional Chinese Medicine. 2–3-month-old mice were 
used for each experiment. 
 
Tissue preparation 
 
The adult mice (20–25g) were anesthetized with sodium pentobarbitone, then 
perfused through the aorta with 0.9% NaCl solution and 4% paraformaldehyde in 0.1 
mol/l phosphate buffer (PB), pH 7.4. The digestive tracts were removed and washed 
with phosphate buffered saline (PBS). After one end of the segment was knotted 
with a silk thread, fixative was injected into the lumen until the space was filled with 
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liquid. The fixative-filled segment was immersed in 4% paraformaldehyde in 0.1 mol/l 
PB, pH7.4, for 4–6 h. The submucosal and myenteric plexuses of the gastric corpus, 
jejunum, ileum, proximal and distal colon of mice were used as whole-mount 
preparations. 
 
Western blot 
 
In order to confirm the specificity of the Pirt antibody, Western blot analysis was 
carried out. Mice were deeply anesthetized with sodium pentobarbital (60mg/kg) 
and killed by decapitation. The proximal colon was rapidly removed, washed with 
ice-cold PBS and lysed with 20 mM Tris–HCl buffer, pH 8.0, containing 1% NP-40, 150 
mM NaCl, 1 mM EDTA, 10% glycerol, 0.1% mercaptoethanol, 0.5 mM dithiothreitol, 
and a mixture of proteinase and phosphatase inhibitors (Sigma). Protein 
concentration was determined by the bovine serum albumin (BCA) protein assay 
method using BCA as standard (BCA protein assay kit from Beyotime). Protein 
samples (100µg or 50µg) were loaded per lane, separated by SDS-PAGE (12% 
polyacrylamide gels) and then were electrotransferred onto nitrocellulose 
membranes. The membranes were blocked with 10% non-fat dry milk in 
Tris-buffered saline for 1 h and incubated overnight at 4°C with Pirt antibody diluted 
1:1,000 in 2% BSA in PBS. The membranes were then incubated with alkaline 
phosphatase-conjugated goat anti-rabbit IgG (Sigma) diluted 1:5,000 in 2% BSA in 
PBS for 1 h at room temperature. The color development was performed with 400 
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g/ml nitro-blue tetrazolium,200 µg/ml 5-bromo-4-chloro-3-indolyl phosphate and 
100 mg/ml levamisole in TSM2 (0.1 mol/l Tris–HCl2 buffer, pH 9.5, 0.1 mol/l NaCl and 
0.05 mol/l MgCl2 in the dark. Bands were scanned using a densitometer (GS-700; 
Bio-Rad Laboratories). Control experiments were carried out with Pirt antibody 
preabsorbed with Pirt peptides.  
 
Immunohistochemistry 
 
The preparations were washed 3×5 min in PBS, and then preincubated in antiserum 
solution 1 (10% normal bovine serum, 0.2% Triton X-100, 0.4% sodium azide in 0.01 
mol/l PBS pH 7.2) for 30 min, followed by incubation with Pirt antibody 
(goat-anti-human, Santa Cruz Biotechnology) diluted 1:100 in antiserum solution 2 (1% 
normal bovine serum, 0.2% Triton X-100, 0.4% sodium azide in 0.01 mol/l PBS pH 
7.2), overnight at 4°C. Subsequently, the preparations were incubated with 
Cy3-conjugated donkey anti-goat IgG diluted 1:400 in antiserum solution 2 for 2 h at 
room temperature. For double immunostaining of Pirt protein with P2X2 receptors 
(1:400, rabbit anti-rat, Roche) or HuD (a neuronal marker, 1:200, rabbit anti-human, 
Santa Cruz), Cy3-conjugated donkey anti-goat IgG (1:400) and FITC-conjugated 
donkey anti-rabbit IgG (1:200) were used. All incubations and reactions were 
separated by 5 -10 min washes in PBS. All secondary antibodies used here were from 
Jackson Immunoresearch Lab. 
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Images were taken with a Nikon digital camera DXM1200 (Nikon, Japan) attached to 
a Nikon Eclipse E600 microscope (Nikon, Japan) or with a confocal microscope 
(Zeiss LSM 710). Images were imported into a graphics package Adobe Photoshop 
5.0.  
 
Quantitative analysis 
Some of the preparations were counterstained with HuD in order to assess the 
percentages of Pirt-positive neurons over total neuron numbers in enteric plexuses. 
For fluorescence immunocytochemistry, whole-mount preparations were used to 
perform a quantitative analysis as described previously (Van Nassauw et al. 2002; Yu 
et al. 2010). Briefly, in each mouse, three whole-mount preparations were analyzed. 
In each preparation, ten visual fields (each area: 0.62 mm2) were chosen randomly. 
Positive-stained cell bodies in the submucosal and myenteric ganglia were counted 
and expressed as the mean ± standard error of the mean.  
 
Co-Immunoprecipitation 
 
Co-immunoprecipitation experiments were performed using the Pierce 
Co-Immunoprecipitation Kit (26149, Pierce; Rockford, IL) as per the manufacturer's 
instructions. Briefly, to minimize non specific binding, 200µg of protein lysates from 
gut were pre-cleared using a control agarose resin. The lysates were applied to 
columns containing 1µg immobilized antibodies (P2X2 or Pirt) covalently linked to an 
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amine-active resin and incubated overnight at 4°C. Equal volumes of the lysates were 
also applied to columns containing control resin and processed the same as the 
antibody coupling resin for negative controls. The co-immunoprecipitate was then 
eluted and analyzed by SDS-PAGE along with the input controls [20]. 
 
Results 
In Pirt-/- mice, the entire open reading frame of Pirt was replaced by the axonal 
tracer farnesylated enhanced green fluorescent protein (EGFPf), whose expression is 
under control of the endogenous Pirt promoter [15]. No positive signal of Pirt was 
found to co-express with GFP positive staining in Pirt-/- mice (Fig. 1 a,b). 
Western blotting, performed on tissue extracts derived from the mouse proximal 
colon (Fig. 1 c), was used to further assess the specificity of the polyclonal Pirt 
antibody. An immunoreactive band was detected at about 20 kDa that corresponded 
to the molecular weight of Pirt (Fig. 1c, lanes 1,2). Pre-adsorption of the antiserum 
with the peptide antigen resulted in the absence of the band (Fig. 1c, lanes 3, 4), 
indicating that the antibodies detected the appropriate antigen sequence. 
 
Pirt immunoreactivity occurred in nerve cell bodies and nerve fibres in the myenteric 
plexus of the stomach, jejunum, ileum and distal colon (Fig. 2a-d), and in the 
submucosal plexus of the jejunum, ileum, proximal and distal colon (Fig. 3a-d). 
Double-labeling studies were conducted to identify the colocalisation of Pirt and 
P2X2 immunoreactivity in the myenteric plexus of the stomach (Fig. 4a-c), jejunum 
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(Fig. 4d-f), ileum (Fig. 5a-c) and distal colon (Fig. 5d-f), and the submucosal plexus of 
the jejunum (Fig. 6a-c), ileum (Fig. 6d-f) and distal colon (Fig. 7a-d). In the myenteric 
plexus of all segments we examined, almost all the Pirt-ir neurons were also 
immunoreactive for P2X2. To further confirm the colocalisation of Pirt and P2X2 at 
the cellular level, we scanned the tissues (the myenteric plexus and submucous 
plexus of the ileum) using confocal microscopy. The results showed the coexpression 
of the two proteins in the same cells (Fig. 8). In Pirt-/- mice, GFP positive straining 
colocalised with P2X2 immunoreactivity in myenteric (Fig. 9a-c) and submucous (Fig. 
9d-f) plexus neurons. Quantitative analysis showed that the vast majority of HuD 
positive neurons were Pirt-positive neurons. All the Pirt positive neurons were Hud 
positive (Fig. 10). The detailed data is shown in Table 1.  
 
To further confirm the co-localization of P2X2 and Pirt in the gut, we performed a 
co-immunoprecipitation (Co-IP) experiment (Fig. 11). Protein extracts of gut were 
subjected to Co-IP with an antibody against P2X2 receptors or control resin, and were 
subsequently analyzed by Western blotting with an anti-Pirt polyclonal antibody. The 
results demonstrated that Pirt was co-precipitated with the anti-P2X2 antibody, but 
not with the control resin in comparison to the input controls. 
 
Discussion 
 
In this study, for the first time, we provide detailed information about the 
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distribution of Pirt protein in the gut nervous system. This pattern is consistent with 
the results found by in situ hybridization experiments [15]. We found that it is widely 
expressed in the myenteric and submucosal plexuses in various regions of the 
gastrointestinal tract of adult mice, including stomach, jejunum, ileum and colon, 
where the expression of P2X receptors has been extensively studied. Pirt 
colocalization and co-immunoprecipitation with P2X2 receptors suggests that it may 
play a functional role in the gut nervous system, but this will need further study. 
 
Our experiments have shown an interaction between P2X2 receptors and Pirt protein, 
but whether the interaction is direct or indirect needs to be further investigated. 
Previous studies have implied that phosphoinositides may be one of the 
intermediaries between the two proteins. For instance, it has been found that the 
C-terminus of the P2X2 receptor binds directly to 
phosphatidyl-inositol-4,5-bisphosphate (PIP2), PIP3 and other phosphoinositides [21]. 
By expressing the target channel in Xenopus oocytes, P2X2 receptors were shown to 
be activated by PIP2 [22], and other work has revealed that heterotrimeric P2X2/3 
receptors are also regulated by phosphoinositides [21]. It has also been shown that 
the C terminus of Pirt protein binds to several phosphoinositides, including PIP2 [15].  
This modulation of P2X receptors and Pirt protein by phospholipids may explain their 
roles under conditions such as chronic pain and immune disorders. 
 
In a hypothesis presented by Burnstock [26], it was proposed that ATP released from 
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mucosal epithelial cells acts on P2X3 and/or P2X2/3 receptors in the subepithelial 
sensory nerve plexus, and that these receptors may contribute to the detection of 
distension or intra-luminal pressure increases resulting in the initiation of reflex 
contractions. Single fiber analysis showed that ATP acts on the terminals of low 
threshold intrinsic enteric sensory neurons to initiate or modulate intestinal reflexes, 
and also acts on the terminals of high threshold extrinsic sensory fibers to initiate 
pain. In P2X3(+/-) and P2X3(-/-) mice, Shinoda and colleagues found different roles of 
P2X3 receptors in colon mechanosensitivity and intracolonic zymosan-produced 
hypersensitivity, a model of persistent colon hypersensitivity without colon 
inflammation [27]. 
 
One more potential role worth discussing here is the role of Pirt protein and P2X 
receptors in the developing gut. Pirt protein was found to be first expressed in DRG 
neurons around embryonic day 11.5 [15]. Our previous studies found a 
developmental expression of P2X3 [28] and P2X5 [29] receptors in the myenteric 
plexus of rat stomach and mouse gut, respectively. P2X receptors are believed to play 
various roles in the development of the nervous system; whether Pirt protein is 
involved or not needs investigating.  
 
Previous works have analyzed the co-expression of the P2X2 receptor with other 
molecules in the gut nervous system, which may prove useful for functional 
investigations. In our previous work, double-labelling experiments demonstrated that 
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about 10–25% of neurons with P2X2 immunoreactivity in the myenteric plexus and 
30–50% in the submucosal plexus expressed Calbindin, a marker for intrinsic sensory 
neurons [11]. Co-expression of P2X2 with neuronal nitric oxide synthase, choline 
acetyltransferase and Calretinin in neurons of the small intestine myenteric plexus 
was detected [30]. While one can speculate on the overlap of P2X2-ir/Pirt-ir cells 
with the above cells types, more information is needed to identify the cell type for a 
better understanding of the role of Pirt protein in the gut. 
 
In conclusion, in this study we describe the expression pattern of Pirt protein and 
P2X2 receptors in various regions of the gastrointestinal tract of the adult mouse, 
and the co-immunoprecipitation of the two proteins from gut tissue. This finding 
may be useful for clarifying the effects of Pirt protein on the wide range of 
physiological functions mediated by P2X receptors. 
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Figure legends 
 
 
Fig. 1 Pirt protein antibody specificity tests. a,b: no positive signal of Pirt was found to co-express 
with GFP positive staining in Pirt-/- mice. C: Lanes 1 (100µg protein samples) and 2 (50µg protein 
samples), immunoreactive band is located at about 20 kDa. Lanes 4 (100µg protein samples) and 
5 (50µg protein samples), preabsorption of the Pirt antisera with its peptide antigen, which 
resulted in the absence of the band. No protein sample was loaded in lane 3, which was used to 
seperate lane 2 and lane 4. 
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Fig. 2 Expression of Pirt protein in the myenteric plexus in various regions of the gastrointestinal 
tract of adult mice. a-d, Pirt-ir (red) in stomach, jejunum, ileum and distal colon, respectively. 
Scale bar: a-d 200µm 
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Fig. 3 Expression of Pirt protein in the submucosal plexus in various regions of the gastrointestinal 
tract of adult mice. a-d, Pirt-ir (red) in jejunum, ileum, proximal and distal colon, respectively. 
Scale bar: a-d 200µm 
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Fig. 4 Colocalization of Pirt-ir and P2X2 receptor-ir in the myenteric plexus of the mouse stomach 
(a-c) and jejunum (d-f). a Pirt-ir cells (red) in the stomach. b P2X2-ir cells (green) in the stomach 
from the same section as (a). c Merged image from (a) and (b). Double-labeled cells are yellow in 
color. d Pirt-ir cells (red) in the jejunum. e P2X2-ir cells (green) in the jejunum from the same 
section as (d). f Merged image from (d) and (e). Double-labeled cells are yellow in color. Scale bar, 
a-f 200µm 
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Fig. 5 Colocalization of Pirt-ir and P2X2 receptor-ir cells in the myenteric plexus of the mouse 
ileum (a-c) and distal colon (d-f). a Pirt-ir cells (red) in the ileum. b P2X2-ir cells (green) in the 
ileum from the same section as (a). c Merged image from (a) and (b). Double-labeled cells are 
yellow in color. d Pirt-ir cells (red) in the distal colon. e P2X2-ir cells (green) in the distal colon 
from the same section as (d). f Merged image from (d) and (e). Double-labeled cells are yellow in 
color. Scale bar, a-f 200µm 
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Fig. 6 Colocalization of Pirt-ir and P2X2 receptor-ir cells in the submucosal plexus of the mouse 
jejunum (a-c) and ileum (d-f). a Pirt-ir cells (red) in the jejunum. b P2X2-ir cells (green) in the 
jejunum from the same section as (a). c Merged image from (a) and (b). Double-labeled cells are 
yellow in color. d Pirt-ir cells (red) in the ileum. e P2X2-ir cells (green) in the ileum from the same 
section as (d). f Merged image from (d) and (e). Double-labeled cells are yellow in color. Scale bar, 
a-f 200µm 
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Fig. 7 Colocalization of Pirt-ir and P2X2 receptor-ir cells in the submucosal plexus of the mouse 
distal colon (a-c). a Pirt-ir cells (red) in the distal colon. b P2X2-ir cells (green) in the distal colon 
from the same section as (a). c Merged image from (a) and (b). Double-labeled cells are yellow in 
color. d a negative control. Scale bar, a-d 200µm 
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Fig. 8 Colocalization of Pirt-ir and P2X2 receptor-ir cells in the myenteric plexus (a-c) and 
submucous plexus (d-f) of the mouse ileum (by using confocal microscopy). a Pirt-ir cells (red) in 
the myenteric plexus. b P2X2-ir cells (green) in the myenteric plexus from the same section as (a). 
c Merged image from (a) and (b). Double-labeled cells are yellow in color. d Pirt-ir cells (red) in 
the submucous plexus. e P2X2-ir cells (green) in the submucous plexus from the same section as 
(d). f Merged image from (d) and (e). Double-labeled cells are yellow in color. Scale bar, a-f 
250µm 
25 
 
 
 
 
Fig. 9 Colocalization of GFP-ir (green) and P2X2 receptor-ir (red) cells in myenteric (a,b,c) and 
submucous (d, e, f) plexus of ileum of Pirt knockout (ko) mice. c and d merged images from (a) 
and (b), and (d) and (e), respectively. Double-labeled neurons are yellow in color. Scale bars, a-f 
200µm 
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Fig. 10 Colocalization of Pirt-ir (red) and HuD-ir (green) cells in myenteric (a,b,c) and submucous 
(d, e, f) plexus of ileum of mouse. c and d merged images from (a) and (b), and (d) and (e), 
respectively. Double-labeled neurons are yellow in color. Scale bars in a-f =200µm.  
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Fig. 11 Co-immunoprecipitation of P2X2 and Pirt. Lysates from proximal colon tissue were 
immunoprecipitated with anti-Pirt or anti-P2X2 antibodies, followed by immunoblotting with 
anti-P2X2 or anti-Pirt antibodies (line 1 and lane 3), respectively. Immunoprecipitation with 
control resin for negative control (line 2 and lane 4). Input represent 5% of the lysates used for 
the immunoprecipitation reaction. The data are representative of three similar experiments. 
Abbreviations: IP, immunoprecipitation; IB, immunoblot. 
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Table 1 Quantitative analysis of double-labeling studies between Pirt-ir neurons and 
HuD-ir Neurons in the submucosal plexus (SMP) and Myenteric plexus (MP) of 
mouse jejunum, ileum and distal colon  
 
Region             Pirt-ir+        HuD-ir +          percentages %  
Jejunum SMP       121±18        131±19               92.7±3.6   
MP       147±20        156±21              94.5±2.7  
Ileum   SMP       152±23      161±24           94.5±1.2  
         MP       161±18      172±17           93.7±2.4  
Distal   SMP       133±21         140±24              95.6±1.5  
Colon    MP       157±12       168±10           93.4±2.4  
 
The first column shows the numbers of Pirt-ir neurons; the second column shows the 
numbers of HuD-ir neurons, which represents the total number of neurons; the 
percentages of Pirt-ir neurons over total neurons (HuD-ir+) are showed in the last 
column.     
 
